ImmunoGen CEO Mark Enyedy's 2019 pay falls 56% to $3.9M
ImmunoGen reports 2019 executive compensation
By ExecPay News
Published: April 28, 2020
ImmunoGen reported fiscal year 2019 executive compensation information on April 28, 2020.
In 2019, six ImmunoGen executives received on average a compensation package of $1.9M, a 40% decrease compared to previous year.
Average pay of disclosed executives at ImmunoGen
Mark J. Enyedy, Chief Executive Officer, received $3.9M in total, which decreased by 56% compared to 2018. 69% of Enyedy's compensation, or $2.7M, was in option awards. Enyedy also received $482K in non-equity incentive plan, $710K in salary, as well as $9K in other compensation.
For fiscal year 2019, the median employee pay was $223,674 at ImmunoGen. Therefore, the ratio of Mark J. Enyedy's pay to the median employee pay was 18 to one.
Anna Berkenblit, Chief Medical Officer, received a compensation package of $1.8M, which is about the same as previous year. 67% of the compensation package, or $1.2M, was in option awards.
Richard J. Gregory, Chief Scientific Officer, earned $1.6M in 2019, a 34% decrease compared to previous year.
Thomas Ryll, Senior Vice President, Technical Operations, received $1.6M in 2019, which decreases by 4% compared to 2018.
Craig Barrows, General Counsel, earned $1.4M in 2019, a 35% decrease compared to previous year.
Theresa G. Wingrove, Senior Vice President, Regulatory Affairs and Quality, received $1.1M in 2019, which decreases by 46% compared to 2018.
Related executives
Mark Enyedy
ImmunoGen
Chief Executive Officer
Anna Berkenblit
ImmunoGen
Chief Medical Officer
Richard Gregory
ImmunoGen
Chief Scientific Officer
Thomas Ryll
ImmunoGen
Senior Vice President, Technical Operations
Craig Barrows
ImmunoGen
General Counsel
Theresa Wingrove
ImmunoGen
Senior Vice President, Regulatory Affairs and Quality
You may also like
Source: SEC filing on April 28, 2020.